• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病区域微观结构退变的进展:一项多中心扩散张量成像研究

Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.

作者信息

Zhang Yu, Wu I-Wei, Tosun Duygu, Foster Eric, Schuff Norbert

机构信息

Department of Veteran Affairs Medical Center, San Francisco, California, United States of America.

Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, United States of America.

出版信息

PLoS One. 2016 Oct 31;11(10):e0165540. doi: 10.1371/journal.pone.0165540. eCollection 2016.

DOI:10.1371/journal.pone.0165540
PMID:27798653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5087900/
Abstract

This study aimed to identify the utility of diffusion tensor imaging (DTI) in measuring the regional distribution of abnormal microstructural progression in patients with Parkinson's disease who were enrolled in the Parkinson's progression marker initiative (PPMI). One hundred and twenty two de-novo PD patients (age = 60.5±9) and 50 healthy controls (age = 60.6±11) had DTI scans at baseline and 12.6±1 months later. Automated image processing included an intra-subject registration of all time points and an inter-subjects registration to a brain atlas. Annualized rates of DTI variations including fractional anisotropy (FA), radial (rD) and axial (aD) diffusivity were estimated in a total of 118 white matter and subcortical regions of interest. A mixed effects model framework was used to determine the degree to which DTI changes differed in PD relative to changes in healthy subjects. Significant DTI changes were also tested for correlations with changes in clinical measures, dopaminergic imaging and CSF biomarkers in PD patients. Compared to normal aging, PD was associated with higher rates of FA reduction, rD and aD increases predominantly in the substantia nigra, midbrain and thalamus. The highest rates of FA reduction involved the substantia nigra (3.6±1.4%/year from baseline, whereas the highest rates of increased diffusivity involved the thalamus (rD: 8.0±2.9%/year, aD: 4.0±1.5%/year). In PD patients, high DTI changes in the substantia nigra correlated with increasing dopaminergic deficits as well as with declining α-synuclein and total tau protein concentrations in cerebrospinal fluid. Increased DTI rates in the thalamus correlated with progressive decline in global cognition in PD. The results suggest that higher rates of regional microstructural degeneration are potential markers of PD progression.

摘要

本研究旨在确定扩散张量成像(DTI)在测量参与帕金森病进展标志物计划(PPMI)的帕金森病患者异常微观结构进展的区域分布中的效用。122例初发帕金森病患者(年龄=60.5±9岁)和50例健康对照者(年龄=60.6±11岁)在基线时及12.6±1个月后进行了DTI扫描。自动化图像处理包括所有时间点的受试者内配准以及与脑图谱的受试者间配准。在总共118个白质和皮质下感兴趣区域估计了DTI变化的年化率,包括分数各向异性(FA)、径向(rD)和轴向(aD)扩散率。采用混合效应模型框架来确定帕金森病患者DTI变化与健康受试者变化相比的差异程度。还测试了帕金森病患者中显著的DTI变化与临床指标、多巴胺能成像和脑脊液生物标志物变化之间的相关性。与正常衰老相比,帕金森病主要与黑质、中脑和丘脑的FA降低率较高以及rD和aD增加率较高相关。FA降低率最高的是黑质(从基线起为3.6±1.4%/年),而扩散率增加率最高的是丘脑(rD:8.0±2.9%/年,aD:4.0±1.5%/年)。在帕金森病患者中,黑质中高DTI变化与多巴胺能缺陷增加以及脑脊液中α-突触核蛋白和总tau蛋白浓度下降相关。丘脑中DTI率增加与帕金森病患者整体认知功能的进行性下降相关。结果表明,较高的区域微观结构退变率是帕金森病进展的潜在标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/ce6d7fa1f9c7/pone.0165540.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/997cbbe3df97/pone.0165540.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/c068b5b22a0f/pone.0165540.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/d7be783ce753/pone.0165540.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/f3a8516fe20f/pone.0165540.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/ce6d7fa1f9c7/pone.0165540.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/997cbbe3df97/pone.0165540.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/c068b5b22a0f/pone.0165540.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/d7be783ce753/pone.0165540.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/f3a8516fe20f/pone.0165540.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/502e/5087900/ce6d7fa1f9c7/pone.0165540.g005.jpg

相似文献

1
Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.帕金森病区域微观结构退变的进展:一项多中心扩散张量成像研究
PLoS One. 2016 Oct 31;11(10):e0165540. doi: 10.1371/journal.pone.0165540. eCollection 2016.
2
Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.帕金森病中多巴胺能末梢功能障碍与基底节和嗅束的微观结构异常的相关性。
Brain. 2013 Oct;136(Pt 10):3028-37. doi: 10.1093/brain/awt234. Epub 2013 Sep 6.
3
Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.应用概率追踪技术评估帕金森病纹状体-黑质连接。
Neuroimage Clin. 2017 Sep 9;16:557-563. doi: 10.1016/j.nicl.2017.09.009. eCollection 2017.
4
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.早期帕金森病伴多巴胺能缺陷患者黑质改变的扩散成像
Mov Disord. 2015 Dec;30(14):1885-92. doi: 10.1002/mds.26325. Epub 2015 Aug 11.
5
High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.高分辨率扩散张量成像表明,早期帕金森病患者黑质内存在不对称的微观结构紊乱。
J Clin Neurosci. 2018 Apr;50:199-202. doi: 10.1016/j.jocn.2018.01.023. Epub 2018 Feb 1.
6
Diffusion basis spectrum imaging detects pathological alterations in substantia nigra and white matter tracts with early-stage Parkinson's disease.扩散张量谱成像检测早期帕金森病患者黑质和白质束的病理改变。
Eur Radiol. 2023 Dec;33(12):9109-9119. doi: 10.1007/s00330-023-09780-0. Epub 2023 Jul 12.
7
Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.帕金森病患者黑质的微观结构异常:基于神经黑色素敏感 MRI 图谱的研究。
Hum Brain Mapp. 2020 Apr 1;41(5):1323-1333. doi: 10.1002/hbm.24878. Epub 2019 Nov 28.
8
Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.弥散张量和限制谱成像反映了帕金森病神经退行性变的不同方面。
PLoS One. 2019 May 31;14(5):e0217922. doi: 10.1371/journal.pone.0217922. eCollection 2019.
9
Progressive Decline in Gray and White Matter Integrity in Parkinson's Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data.帕金森病中灰质和白质完整性的渐进性下降:帕金森病纵向进展标志物计划扩散张量成像数据分析
Front Aging Neurosci. 2018 Oct 8;10:318. doi: 10.3389/fnagi.2018.00318. eCollection 2018.
10
Differences in Gaussian diffusion tensor imaging and non-Gaussian diffusion kurtosis imaging model-based estimates of diffusion tensor invariants in the human brain.基于高斯扩散张量成像和非高斯扩散峰度成像模型的人脑扩散张量不变量估计差异。
Med Phys. 2016 May;43(5):2464. doi: 10.1118/1.4946819.

引用本文的文献

1
White matter microstructural alterations and brain metabolism distributions in Parkinson's disease.帕金森病中的白质微观结构改变及脑代谢分布
Brain Imaging Behav. 2025 Aug;19(4):938-948. doi: 10.1007/s11682-025-01023-8. Epub 2025 Jun 3.
2
Early Alterations in De Novo Parkinson's Disease Revealed by Diffusion Tensor Imaging: Preliminary Study.扩散张量成像揭示的新发帕金森病早期改变:初步研究
Diagnostics (Basel). 2025 Mar 25;15(7):841. doi: 10.3390/diagnostics15070841.
3
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.

本文引用的文献

1
Aberrant nigral diffusion in Parkinson's disease: A longitudinal diffusion tensor imaging study.帕金森病中黑质的异常扩散:一项纵向扩散张量成像研究。
Mov Disord. 2016 Jul;31(7):1020-6. doi: 10.1002/mds.26606. Epub 2016 Apr 22.
2
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.早期帕金森病伴多巴胺能缺陷患者黑质改变的扩散成像
Mov Disord. 2015 Dec;30(14):1885-92. doi: 10.1002/mds.26325. Epub 2015 Aug 11.
3
Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture.
帕金森病患者脑脊液α-突触核蛋白聚集的影像学标志物。
NPJ Parkinsons Dis. 2025 Jan 3;11(1):7. doi: 10.1038/s41531-024-00854-4.
4
Serum glial cell line-derived neurotrophic factor: a potential biomarker for white matter alteration in Parkinson's disease with mild cognitive impairment.血清胶质细胞源性神经营养因子:帕金森病伴轻度认知障碍患者白质改变的潜在生物标志物。
Front Neurosci. 2024 Oct 24;18:1370787. doi: 10.3389/fnins.2024.1370787. eCollection 2024.
5
Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson's disease.弥散张量指标与新发帕金森病的运动及非运动症状
Neuroradiology. 2024 Nov;66(11):1955-1966. doi: 10.1007/s00234-024-03452-6. Epub 2024 Aug 27.
6
Microstructural alterations in white matter and related neurobiology based on the new clinical subtypes of Parkinson's disease.基于帕金森病新临床亚型的白质微观结构改变及相关神经生物学
Front Neurosci. 2024 Aug 1;18:1439443. doi: 10.3389/fnins.2024.1439443. eCollection 2024.
7
A worldwide study of white matter microstructural alterations in people living with Parkinson's disease.一项针对帕金森病患者白质微观结构改变的全球研究。
NPJ Parkinsons Dis. 2024 Aug 11;10(1):151. doi: 10.1038/s41531-024-00758-3.
8
Toward diffusion tensor imaging as a biomarker in neurodegenerative diseases: technical considerations to optimize recordings and data processing.迈向将扩散张量成像作为神经退行性疾病生物标志物:优化记录和数据处理的技术考量
Front Hum Neurosci. 2024 Apr 2;18:1378896. doi: 10.3389/fnhum.2024.1378896. eCollection 2024.
9
Serial deep gray nuclear DTI changes in Parkinson's disease over twelve years.帕金森病十二年期间黑质核的系列扩散张量成像变化
Front Aging Neurosci. 2023 Jun 20;15:1169254. doi: 10.3389/fnagi.2023.1169254. eCollection 2023.
10
Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3.与疾病相关的少突胶质细胞特征在3型脊髓小脑共济失调中存在时空失调。
Front Neurosci. 2023 Feb 15;17:1118429. doi: 10.3389/fnins.2023.1118429. eCollection 2023.
帕金森病中黑质的分数各向异性:一幅复杂的图景。
Eur J Neurol. 2015 Oct;22(10):1408-14. doi: 10.1111/ene.12760. Epub 2015 Jun 29.
4
Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.帕金森病黑质内游离水的纵向变化。
Brain. 2015 Aug;138(Pt 8):2322-31. doi: 10.1093/brain/awv136. Epub 2015 May 16.
5
Advances in understanding mechanisms of thalamic relays in cognition and behavior.丘脑中继在认知和行为中的机制研究进展。
J Neurosci. 2014 Nov 12;34(46):15340-6. doi: 10.1523/JNEUROSCI.3289-14.2014.
6
Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.轻度认知障碍与帕金森病患者皮质变薄的纵向速度有关。
Brain. 2014 Apr;137(Pt 4):1120-9. doi: 10.1093/brain/awu036. Epub 2014 Mar 10.
7
Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.脑铁成像与弥散模式:帕金森病早期的随访研究。
Acad Radiol. 2014 Jan;21(1):64-71. doi: 10.1016/j.acra.2013.09.018.
8
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.脑脊液β-淀粉样蛋白 1-42、T 蛋白、P 蛋白 181 和α-突触核蛋白水平与未经药物治疗的早期帕金森病患者临床特征的关系。
JAMA Neurol. 2013 Oct;70(10):1277-87. doi: 10.1001/jamaneurol.2013.3861.
9
Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis.帕金森综合征的弥散张量成像:系统评价和荟萃分析。
Neurology. 2013 Feb 26;80(9):857-64. doi: 10.1212/WNL.0b013e318284070c.
10
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects.帕金森病患者的总脑脊液 α-突触核蛋白含量低于健康受试者。
Neurosci Lett. 2013 Jan 4;532:44-8. doi: 10.1016/j.neulet.2012.11.004. Epub 2012 Nov 10.